ClinicalTrials.govpublic full text
ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness
early and locally advanced breast cancer, early breast cancer, locally advanced breast cancer, neoadjuvant endocrine therapy, chemotherapy, hr-positive, her2-negative, abcsg 61, teodor, endocrine responsive, natera, in-vitro diagnostic
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 869802
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.